![](/img/cover-not-exists.png)
REASSURE observational study of radium-223 (Ra-223): First interim results by prior/concomitant treatment (Tx) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) enrolled in Europe
Logue, J., Schostak, M., Baldari, S., Schrijvers, D., Sandzén, J., Meidahl Petersen, P., Procopio, G., Strauß, A., Borrega, P., Rebmann, U., Miller, K., Kalinovský, J., De Sanctis, Y., Sternberg, C.,Volume:
17
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(18)32277-2
Date:
March, 2018
File:
PDF, 87 KB
english, 2018